Quantitative and immunohistochemical evaluation of PCNA, androgen receptors, apoptosis, and glutathione-S-transferase PI on preneoplastic changes induced by cadmium and zinc chloride in the rat ventral prostate

Prostate

Volumn 63, Issue 4, 2005, Pages 347-357

  Arriazu, Riánsares ^a   Pozuelo, José M ^a   Martín, Rocío ^b   Rodríguez, Rosario ^a   Santamaría, Luis ^c  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^c AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

Author keywords

Apoptosis; Cadmium; Dysplasia; GSTP1; PCNA; Rat prostate; Zinc

Indexed keywords

ANDROGEN RECEPTOR; CADMIUM; CYCLINE; DNA FRAGMENT; GLUTATHIONE TRANSFERASE; ZINC CHLORIDE;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DENSITY; CELL PROLIFERATION; DYSPLASIA; EPITHELIUM CELL; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CADMIUM; CELL DIVISION; CHLORIDES; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; ZINC COMPOUNDS;

EID: 18644386793     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20192     Document Type: Article

References (44)

1. Bostwick DG. Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 1996;30:145-152.
2. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-134.
3. Bonkhoff H, Remberger K. Diagnostic criteria and differential diagnosis of prostatic intraepithelial neoplasia. Pathologe 1998;19:33-41.
4. Marshall JR. High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research. IARC Sci Publ 2001;154:191-198.
5. Pollard M, Wolter W, Sun L. Diet and the duration of testosterone- dependent prostate cancer in Lobund-Wistar rats. Cancer Lett 2001;173:127-131.
6. Pollard M, Wolter W. Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 2000;45:101-105.
7. Morrissey C, Buser A, Scolaro J, O'Sullivan J, Moquin A, Tenniswood M. Changes in hormone sensitivity in the ventral prostate of aging Sprague-Dawley rats. J Androl 2002;23:341-351.
8. Shirai T, Takahashi S, Cui L, Futakuchi M, Kato K, Tamano S, Imaida K. Experimental prostate carcinogenesis - Rodent models. Mutat Res 2000;462:219-226.
9. Bosland MC. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer. Eur Urol 1999;35:459-463.
10. Nakamura K, Yasunaga Y, Ko D, Xu LL, Moul JW, Peehl DM, Srivastava S, Rhim JS. Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int J Oncol 2002;3:543-547.
11. Waalkes MP. Cadmium carcinogenesis in review. J Inorg Biochem 2000;79:241-244.
12. King LM, Banks WA, George WJ. Differences in cadmium transport to the testis, epididymis, and brain in cadmium-sensitive and -resistant murine strains 129/J and A/J. J Pharmacol Exp Ther 1999;289:825-830.
13. Kang Z, Pirskanen A, Jänne OA, Palvimo JJ. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 2002;277:48366-48371.
14. Nicholson B, Theodorescu D. Molecular therapeutics in prostate cancer. Histol Histopathol 2003;18:275-298.
15. Waalkes MP, Anver M, Diwan BA. Carcinogenic effects of cadmium in the noble (NBL/Cr) rat: Induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate. Toxicol Sci 1999;52:154-161.
16. Rushmore TH, Pickett CB. Glutathione S-Transferases: Structure, regulation, and therapeutic implications. J Biol Chem 1993;268:11475-11478.
17. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG. Cytidine methylation of regulatory sequences near the p-class glutathione S-transferase gene accompanies human. Proc Natl Acad Sci USA 1994;91:11733-11737.
18. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-1992.
19. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ. Detailed methylation analysis of the glutathione-S-transferase pi (GSTP1) gene in prostate cancer. Oncogene 1999;18:1313-1324.
20. Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, Deweese TL, De Marzo AM, Nelson WG. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 2001;159:1815-1826.
21. Nelson WG, Deweese TL, DeMarzo AM. The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev 2002;21:3-16.
22. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988;96:379-394.
23. Nevalainem MT, Valve EM, Ingleton PM, Harkönen PL. Expression and hormone regulation of prolactin receptors in rat dorsal and lateral prostate. Endocrinology 1996;137:3078-3088.
24. Martin JJ, Martin R, Codesal J, Fraile B, Paniagua R, Santamaria L. Cadmium chloride-induced dysplastic changes in the ventral rat prostate: An immunohistochemical and quantitative study. Prostate 2001;46:11-20.
25. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
26. Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride. Endocrinology 1995;136:741-748.
27. Wreford NG. Theory and practice of stereological techniques applied to the estimation of cell number and nuclear volume in the testis. Microsc Res Tech 1995;32:423-436.
28. Howard CV, Reed MG. Number estimation. In: Howard CV, Reed MG, editors. Unbiased stereology. Three-dimensional measurement in microscopy. Oxford: Bios Scientific Publishers; 1998. pp 69-105.
29. Shirai T, Iwasaki S, Masui T, Mori T, Kato T, Ito N. Enhancing effect of cadmium on rat ventral prostate carcinogenesis induced by 3,2′-dimethyl-4- aminobiphenyl. Jpn J Cancer Res 1993;84:1023-1030.
30. Pylkkanen L, Makela S, Santti R. Animal models for the preneoplastic lesions of the prostate. Eur Urol 1996;30:243-248.
31. Schleicher RL, Fallon MT, Austin GE, Zhang M, Dillehay DL, Collins DC. Intravenous versus intraprostatic administration of N-methyl-N-nitrosourea to induce prostate cancer in rats. Prostate 1996;28:32-43.
32. Golomb E, Kruglikova A, Duir D, Parnes N, Abramovici A. Onduction of atypical prostatic hyperplasia in rats by sympathomimetic stimulation. Prostate 1998;34:214-221.
33. Yan H, Carter CE, Xu C, Singh PK, Jones MM, Johnson JE, Dietrich MS. Cadmium-induced apoptosis in the urogenital organs of the male rat and its suppression by chelation. J Toxicol Environ Health 1997;52:149-168.
34. Achanzar WE, Diwan BA, Liu J, Quader ST, Webber MM, Waalkes MP. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res 2001;61:455-458.
35. Waalkes MP, Rehm S. Carcinogenicity of oral cadmium in the male Wistar (WF-NCr) rat. Effect of chronic dietary zinc deficiency. Fund Appl Toxicol 1992;19:512-520.
36. Montironi R, Magi-Galluzzi C, Marina S, Diamanti L. Quantitative characterization of the frequency and location of cell proliferation and death in prostate pathology. J Cell Biochem Suppl 1994;19:238-245.
37. Erbersdobler A, Fritz H, Schnoger S, Graefen M, Hammerer P, Huland H, Henke RP. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: Differences between tumours located in the transition zone and in the peripheral zone. Eur Urol 2002;41:40-46.
38. Waalkes MP, Coogan TP, Barter RA. Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit Rev Toxicol 1992;22:175-201.
39. Bentel JM, Tilley WD. Androgen receptors in prostate cancer. J Endocrinol 1996;151:1-11.
40. De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG. Human prostate cancer precursors and pathobiology. Urology 2003;62 :55-62.
41. Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer. J Cell Biochem 2004;91540-552.
42. Kang GH, Lee S, Lee HJ, Hwang KS. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia. J Pathol 2004;202:233-240.
43. Yamanaka M, Watanabe M, Yamada Y, Takagi A, Murata T, Takahashi H, Suzuki H, Ito H, Tsukino H, Katoh T, Sugimura Y, Shiraishi T. Altered methylation of multiple genes in carcinogenesis of the prostate. Int J Cancer 2003;106:382-387.
44. Jeronimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2002;11:445-450.